Aug 3 (Reuters) – Private equity firms are mulling over a $10 billion plan to buy and merge older drug brands of Britain’s GlaxoSmithKline and France’s Sanofi, the Financial Times reported on Sunday,…

from Reuters: Private Equity http://ift.tt/1lqkjz4
via IFTTT

Advertisements